Peter L. Rosenblatt, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 11 | 2022 | 134 | 4.800 |
Why?
|
| Gynecologic Surgical Procedures | 15 | 2022 | 336 | 4.720 |
Why?
|
| Uterine Prolapse | 10 | 2022 | 73 | 2.930 |
Why?
|
| Suburethral Slings | 6 | 2021 | 76 | 2.050 |
Why?
|
| Laparoscopy | 12 | 2022 | 2121 | 1.900 |
Why?
|
| Urinary Incontinence, Stress | 11 | 2019 | 183 | 1.840 |
Why?
|
| Surgical Mesh | 11 | 2022 | 256 | 1.650 |
Why?
|
| Pelvic Floor | 5 | 2019 | 138 | 1.630 |
Why?
|
| Vagina | 6 | 2021 | 825 | 1.560 |
Why?
|
| Fecal Incontinence | 3 | 2021 | 240 | 1.470 |
Why?
|
| Hysterectomy | 6 | 2021 | 927 | 1.390 |
Why?
|
| Cervix Uteri | 4 | 2021 | 591 | 0.940 |
Why?
|
| Anal Canal | 4 | 2021 | 376 | 0.820 |
Why?
|
| Patient Satisfaction | 5 | 2021 | 3391 | 0.760 |
Why?
|
| Directive Counseling | 1 | 2020 | 166 | 0.680 |
Why?
|
| Urologic Surgical Procedures | 3 | 2015 | 301 | 0.640 |
Why?
|
| Urinary Incontinence | 3 | 2019 | 494 | 0.640 |
Why?
|
| Muscarinic Antagonists | 2 | 2016 | 137 | 0.610 |
Why?
|
| Urination Disorders | 5 | 2018 | 241 | 0.590 |
Why?
|
| Urination | 3 | 2016 | 204 | 0.560 |
Why?
|
| Scopolamine | 1 | 2016 | 99 | 0.540 |
Why?
|
| Conization | 1 | 2014 | 14 | 0.510 |
Why?
|
| Rectovaginal Fistula | 1 | 2014 | 11 | 0.490 |
Why?
|
| Urethra | 3 | 2013 | 408 | 0.470 |
Why?
|
| Hysterectomy, Vaginal | 3 | 2022 | 37 | 0.470 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 161 | 0.460 |
Why?
|
| Uterine Diseases | 1 | 2014 | 135 | 0.450 |
Why?
|
| Longitudinal Ligaments | 1 | 2012 | 27 | 0.440 |
Why?
|
| Urinary Bladder Diseases | 2 | 2005 | 166 | 0.440 |
Why?
|
| Exercise Therapy | 1 | 2019 | 904 | 0.420 |
Why?
|
| Urodynamics | 7 | 2013 | 347 | 0.410 |
Why?
|
| Neurotransmitter Agents | 1 | 2015 | 647 | 0.400 |
Why?
|
| Urinary Bladder | 2 | 2016 | 1171 | 0.380 |
Why?
|
| Prosthesis Implantation | 2 | 2014 | 641 | 0.370 |
Why?
|
| Defecation | 1 | 2012 | 188 | 0.370 |
Why?
|
| Emotions | 1 | 2021 | 2657 | 0.340 |
Why?
|
| Sacrum | 3 | 2021 | 289 | 0.320 |
Why?
|
| Electric Stimulation Therapy | 3 | 2009 | 605 | 0.320 |
Why?
|
| Treatment Outcome | 21 | 2022 | 62966 | 0.300 |
Why?
|
| Cystoscopy | 2 | 2005 | 134 | 0.290 |
Why?
|
| Postoperative Period | 5 | 2020 | 1839 | 0.290 |
Why?
|
| Operating Rooms | 1 | 2013 | 813 | 0.280 |
Why?
|
| Female | 43 | 2022 | 379592 | 0.280 |
Why?
|
| Attitude to Health | 1 | 2015 | 2051 | 0.260 |
Why?
|
| Preoperative Care | 2 | 2017 | 2245 | 0.260 |
Why?
|
| Quality of Life | 5 | 2019 | 12730 | 0.250 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3667 | 0.240 |
Why?
|
| Middle Aged | 29 | 2021 | 213127 | 0.230 |
Why?
|
| Uterus | 2 | 2021 | 710 | 0.230 |
Why?
|
| Foreign-Body Migration | 1 | 2005 | 221 | 0.220 |
Why?
|
| Gynecology | 2 | 2007 | 509 | 0.220 |
Why?
|
| Pelvis | 1 | 2007 | 730 | 0.220 |
Why?
|
| Attitude | 1 | 2007 | 772 | 0.210 |
Why?
|
| Spinal Nerve Roots | 1 | 2002 | 124 | 0.200 |
Why?
|
| Humans | 47 | 2022 | 742088 | 0.200 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 1385 | 0.190 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2451 | 0.170 |
Why?
|
| Adult | 22 | 2021 | 213712 | 0.160 |
Why?
|
| Retrospective Studies | 10 | 2021 | 77098 | 0.160 |
Why?
|
| Hydronephrosis | 1 | 1999 | 269 | 0.150 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 201 | 0.150 |
Why?
|
| Cystocele | 2 | 2017 | 5 | 0.140 |
Why?
|
| Rectocele | 2 | 2017 | 22 | 0.140 |
Why?
|
| Citric Acid | 1 | 2017 | 126 | 0.140 |
Why?
|
| Enema | 1 | 2017 | 141 | 0.140 |
Why?
|
| Cattle | 1 | 2022 | 3923 | 0.140 |
Why?
|
| Tibial Nerve | 2 | 2009 | 57 | 0.140 |
Why?
|
| Cathartics | 1 | 2017 | 125 | 0.140 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2016 | 118 | 0.130 |
Why?
|
| Cellulose, Oxidized | 1 | 1994 | 12 | 0.130 |
Why?
|
| Surgical Instruments | 1 | 2018 | 394 | 0.130 |
Why?
|
| Aged | 17 | 2021 | 162944 | 0.130 |
Why?
|
| Physicians | 1 | 2013 | 4554 | 0.130 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 39004 | 0.120 |
Why?
|
| Polypropylenes | 1 | 2014 | 63 | 0.120 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15530 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2019 | 8297 | 0.120 |
Why?
|
| Reoperation | 3 | 2021 | 4200 | 0.120 |
Why?
|
| Administration, Cutaneous | 1 | 2016 | 711 | 0.120 |
Why?
|
| Preoperative Period | 1 | 2016 | 546 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2022 | 53187 | 0.120 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 57683 | 0.120 |
Why?
|
| Phosphates | 1 | 2017 | 786 | 0.110 |
Why?
|
| Organometallic Compounds | 1 | 2017 | 665 | 0.110 |
Why?
|
| Uterine Hemorrhage | 1 | 2014 | 255 | 0.110 |
Why?
|
| Manometry | 1 | 2014 | 444 | 0.100 |
Why?
|
| Hernia | 1 | 2012 | 71 | 0.100 |
Why?
|
| Cross-Sectional Studies | 3 | 2020 | 24913 | 0.100 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 425 | 0.090 |
Why?
|
| Recurrence | 2 | 2021 | 8333 | 0.090 |
Why?
|
| Menorrhagia | 1 | 2010 | 63 | 0.090 |
Why?
|
| Phenylpropanolamine | 1 | 2009 | 15 | 0.090 |
Why?
|
| Cresols | 1 | 2009 | 28 | 0.090 |
Why?
|
| Hysteroscopy | 1 | 2010 | 102 | 0.090 |
Why?
|
| Posture | 1 | 2013 | 958 | 0.080 |
Why?
|
| Pelvic Pain | 1 | 2010 | 273 | 0.080 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2009 | 106 | 0.080 |
Why?
|
| Muscular Diseases | 1 | 2012 | 557 | 0.070 |
Why?
|
| Constipation | 1 | 2012 | 546 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 3839 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2012 | 1203 | 0.070 |
Why?
|
| Informed Consent | 1 | 2012 | 991 | 0.070 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2005 | 65 | 0.060 |
Why?
|
| Serotonin Antagonists | 1 | 2005 | 146 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 35342 | 0.060 |
Why?
|
| Demography | 2 | 2007 | 1650 | 0.060 |
Why?
|
| Leiomyoma | 1 | 2010 | 728 | 0.060 |
Why?
|
| Counseling | 1 | 2012 | 1521 | 0.060 |
Why?
|
| Benzylamines | 1 | 2005 | 226 | 0.060 |
Why?
|
| Cadaver | 2 | 2019 | 1333 | 0.060 |
Why?
|
| Isoquinolines | 1 | 2005 | 368 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 7276 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2009 | 840 | 0.060 |
Why?
|
| Hospitals, Teaching | 1 | 2008 | 1179 | 0.060 |
Why?
|
| Hallucinogens | 1 | 2005 | 180 | 0.050 |
Why?
|
| Young Adult | 3 | 2021 | 56350 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 2011 | 0.050 |
Why?
|
| Biopsy | 1 | 2014 | 6756 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2012 | 1638 | 0.050 |
Why?
|
| Uterine Neoplasms | 1 | 2010 | 1513 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2018 | 9846 | 0.050 |
Why?
|
| Postoperative Complications | 4 | 2018 | 15244 | 0.050 |
Why?
|
| Time Factors | 2 | 2021 | 40054 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 1028 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21719 | 0.040 |
Why?
|
| Perineum | 1 | 2019 | 211 | 0.040 |
Why?
|
| Abdominal Wall | 1 | 2019 | 155 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2002 | 824 | 0.040 |
Why?
|
| Ureteral Obstruction | 1 | 1999 | 293 | 0.040 |
Why?
|
| Adolescent | 3 | 2021 | 85649 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 6347 | 0.040 |
Why?
|
| Prevalence | 1 | 2013 | 15194 | 0.030 |
Why?
|
| Polyethylene Terephthalates | 1 | 1995 | 116 | 0.030 |
Why?
|
| Pressure | 1 | 1998 | 1203 | 0.030 |
Why?
|
| Cough | 1 | 1998 | 555 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3769 | 0.030 |
Why?
|
| Male | 5 | 2020 | 349538 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 1589 | 0.030 |
Why?
|
| Urogenital Surgical Procedures | 2 | 2002 | 35 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 2110 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4465 | 0.030 |
Why?
|
| Animals | 1 | 2022 | 168561 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6452 | 0.020 |
Why?
|
| Comprehension | 1 | 2012 | 608 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5062 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 2009 | 965 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2005 | 379 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 40450 | 0.020 |
Why?
|
| Ligaments | 1 | 2005 | 127 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 2005 | 592 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 322 | 0.010 |
Why?
|
| Wound Healing | 1 | 1994 | 2781 | 0.010 |
Why?
|
| Stents | 1 | 1994 | 3276 | 0.010 |
Why?
|
| Algorithms | 1 | 2002 | 13853 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 2372 | 0.010 |
Why?
|
| Brain | 1 | 2005 | 26343 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 3915 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2005 | 2658 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 9387 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2000 | 2414 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2005 | 5100 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 6259 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2005 | 8925 | 0.000 |
Why?
|
| Health Status | 1 | 2000 | 4030 | 0.000 |
Why?
|